A 2017 meta-analysis [39] reported that magnesium supplementation reduced FBG (WMD −6.253 mg/dL, CI −6.253 to −1.904) but not HbA1c or fasting insulin in the subgroup of people with T2D, compared with placebo. Here, INS is linked to type 2 diabetes mellitus.